JOHNSON JOHN sold XERS
August 13, 2025 · Form 4 insider transaction
JOHNSON JOHN sold 107,500 shares of Xeris Biopharma Holdings, Inc. at $7.32 per share, a transaction worth $786.5K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
107,500
Price
$7.32
Total value
$786.5K
InsiderJOHNSON JOHN
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateAugust 13, 2025
Filing dateAugust 15, 2025
Shares owned after833,483
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The price reported in is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.250 to $7.420, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.